Rational choice of monotherapy for the treatment of type 2 diabetes mellitus based on the pharmacoeconomical analysis
DOI :
https://doi.org/10.15587/2313-8416.2014.32109Mots-clés :
diabetes mellitus, retrospective analysis, monotherapy, cost-effectiveness analysis, sensitivity analysisRésumé
Research was conducted to scientific justification of rational choice of monotherapy diabetes mellitus (DM) type 2 based on the pharmacoeconomical analysis. It has been found that the unit of efficiency was the cheapest in the scheme of the monotherapy with gliclazide and most expensive – in the scheme of the monotherapy with metformin.
Références
Dovidnik osnovnih pokaznikiv diyalnosti endokrinologichnoyi sluzhbi Ukrayini za 2011, 2012, 2013.
Nakaz MOZ Ukrayini vid 21.12.2012 N 1118 «Unifikovaniy klinichniy protokol pervinnoyi ta vtorinnoyi (spetsializovanoyi) medichnoyi dopomogi».
Nathan, D. M., Buse, J. B., Davidson, M. B. et al. (2009). Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiationand adjustment of therapy. Diabetes Care, 32 (1), 193–203. doi: 10.2337/dc08-2195
Dedov, I. I., Shestakova, M. V., Ametov, A. S. et. al. (2011). Konsensus soveta ekspertov Rossiyskoy assotsiatsii endokrinologov po initsiatsii i intensifikatsii saharosnizhayushchey terapii u bolnyh saharnym diabetom 2 tipa. Normativnye dokumenty. Saharnyy diabet, 4, 7–17
Zherdova, N. M. (2014). Individualniy pidhid do likuvannya hvorih na tsukroviy diabet 2-go tipu. Ukrayinskiy medichniy chasopis, 1 (99), 37–40.
Yagudinа, R. I., Kulikov, A. Yu., Arinina, E. E. (2011). Farmakoekonomika saharnogo diabeta vtorogo tipa. Moscow: OOO «Meditsinskoe informatsionnoe agentstvo», 64–66.
Pravinkumar, I., Тalelem, G. (2012). Adverse effects of metformin in combination with glimepiride and glibenclamide in patients with type 2 diabetes mellitus. Asian Journal of Pharmaceutical and Clinical Research, 5, 108–110.
Yakovleva, L. V., Kirichenko, O. N. (2011). Farmakoepidemiologichne i farmakoekonomicheskiy otsinka likuvannya diabetu. Klinichna endokrinologiya ta endokrinna hirurgiya, 2, 10–20.
Abdulganiyu, G., Fola, T. (2014). Cost-cost analysis of anti-diabetic therapy in a tertiary healthcare. International journal of pharmacy and pharmaceutical sciences, 6, 281–286.
Guidelines for ATC classification and DDD assignment 2013 р.15electronic resource. Available at: www.whocc.no/atc_ddd_index
Register wholesale prices of medicines electronic resource. Available at: www.moz.gov.ua/ua/register_prices_drugs
Téléchargements
Publié-e
Numéro
Rubrique
Licence
(c) Tous droits réservés Tatyana Ivko, Tamara Germanyuk 2014
Cette œuvre est sous licence Creative Commons Attribution 4.0 International.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
